Literature DB >> 2774698

Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.

T H Ståhlberg1, J Heesemann, K Granfors, A Toivanen.   

Abstract

The IgM, IgG, and IgA antibody responses of patients with Yersinia enterocolitica O:3 infection were studied by immunoblotting with plasmid encoded released proteins of Y enterocolitica as the antigens. The results indicate that antibodies of all three classes are most consistently directed against the proteins of molecular weights 25,000 and 36,000. Less than two months after the onset of infection 18 of the 19 patients with yersinia triggered reactive arthritis had IgA class antibodies against the released protein of mol. wt 36,000, whereas only eight of the 17 patients with non-arthritic yersiniosis had these antibodies. The same difference between the arthritic and non-arthritic patients was observed also 8-12 months after the onset of infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774698      PMCID: PMC1003819          DOI: 10.1136/ard.48.7.577

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp.

Authors:  I Bölin; A Forsberg; L Norlander; M Skurnik; H Wolf-Watz
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Arthritis associated with Yersinia enterocolitica infection.

Authors:  P Ahvonen; K Sievers; K Aho
Journal:  Acta Rheumatol Scand       Date:  1969

3.  Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease.

Authors:  K Granfors
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

4.  Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis.

Authors:  J Heesemann; C Keller; R Morawa; N Schmidt; H J Siemens; R Laufs
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

5.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

6.  Genetically manipulated virulence of Yersinia enterocolitica.

Authors:  J Heesemann; B Algermissen; R Laufs
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Immune response to plasmid- and chromosome-encoded Yersinia antigens.

Authors:  G Mazza; A E Karu; D T Kingsbury
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

8.  Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media.

Authors:  J Heesemann; U Gross; N Schmidt; R Laufs
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins.

Authors:  D A Portnoy; H Wolf-Watz; I Bolin; A B Beeder; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.

Authors:  A Toivanen; K Granfors; R Lahesmaa-Rantala; R Leino; T Ståhlberg; R Vuento
Journal:  Immunol Rev       Date:  1985-08       Impact factor: 12.988

View more
  9 in total

1.  First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Germany.

Authors:  S Schubert; J Bockemühl; U Brendler; J Heesemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-24       Impact factor: 3.267

2.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Antibody response against 26 and 46 kilodalton released proteins of yersinia in yersinia triggered reactive arthritis.

Authors:  O Mäki-Ikola; M Pulz; J Heesemann; R Lahesmaa; R Saario; A Toivanen; K Granfors
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

4.  Yersinia Yop-specific IgA antibodies in Hungarian blood donors.

Authors:  A Sonnevend; E Czirók; T Pál
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

5.  Bacteriological and serological findings in a further case of transfusion-mediated Yersinia enterocolitica sepsis.

Authors:  E Strobel; J Heesemann; G Mayer; J Peters; S Müller-Weihrich; P Emmerling
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J Heesemann; J J Festen; P M Houtman; P L van Oyen
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

7.  Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi.

Authors:  Mindy L Rawlins; Cecilia Gerstner; Harry R Hill; Christine M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

8.  Comparison of crossed immunoelectrophoresis, enzyme-linked immunosorbent assays, and tube agglutination for serodiagnosis of Yersinia enterocolitica serotype O:3 infection.

Authors:  A Paerregaard; G H Shand; K Gaarslev; F Espersen
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

Review 9.  A review of serological tests to assist diagnosis of reactive arthritis: critical appraisal on methodologies.

Authors:  Tamara Tuuminen; Kari Lounamo; Marjatta Leirisalo-Repo
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.